Decheng Capital Management III (Cayman), LLC
Top Portfolio Positions
17 positions ·
$159,478,151 total
· as of Sep 30, 2023
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
2,099,583 | $42,117,634 | 26.41% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
1,459,700 | $17,049,296 | 10.69% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
869,790 | $15,612,730 | 9.79% | |
| TXG |
10x Genomics, Inc.
Healthcare
|
359,554 | $14,831,602 | 9.30% | |
| PACB |
Pacific Biosciences Of California, Inc.
Healthcare
|
1,463,872 | $12,223,331 | 7.66% | |
| ILMN |
Illumina, Inc.
Healthcare
|
80,859 | $10,797,983 | 6.77% | |
| AURA |
Aura Biosciences, Inc.
Healthcare
|
1,163,123 | $10,433,213 | 6.54% | |
| LNTH |
Lantheus Holdings, Inc.
Healthcare
|
142,196 | $9,879,778 | 6.20% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
850,000 | $8,814,500 | 5.53% | |
| BYSI |
BeyondSpring Inc.
Healthcare
|
4,958,143 | $3,966,514 | 2.49% |
Portfolio Trend
7 quarters · across all stocks
Holdings in BYSI
Shares Held
Position Value (USD)
7 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $6,195,144 | 3,800,702 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $10,648,980 | 4,531,481 | Shares | Sole | 2025-08-14 | |
| 2023-09-30 | $3,966,514 | 4,958,143 | Shares | Sole | 2023-12-12 | |
| 2023-03-31 | $5,553,120 | 4,958,143 | Shares | Sole | 2023-05-10 | |
| 2022-09-30 | $4,908,561 | 4,958,143 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $7,139,724 | 4,958,142 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $10,907,912 | 4,958,142 | Shares | Sole | 2022-05-10 | |
| No 13F history on record for this holder in this stock. | ||||||